Medicine
Ceftazidime 6 g powder for injection
Ceftazidime 6 g powder for injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Ceftazidime for injection, USP in the dry state should be stored at 20ºC to…
Key facts
- Active ingredient (INN)
- Ceftazidime
- Brand
- Sold under the generic name
- Strength
- 6 g
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 6 vials
- Manufacturer
- WG Critical Care
- Origin register
- US FDA, United States
- Storage
- Ceftazidime for injection, USP in the dry state should be stored at 20ºC to 25°C (68ºF to 77°F) and protected from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DD02 Ceftazidime
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 January 2013
- Identifiers
- RxCUI 242800DailyMed set ID 22d6534c-4488-48a1-8d78-e2fb908259deNDC 44567-237Application ANDA062640
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 vial, pharmacy bulk package in 1 carton / 1 injection, powder, for solution in 1 vial, pharmacy bulk package | 44567-237-06 | WG Critical Care | 31 January 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 July 1985 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ceftazidime 6 g powder for injection.
Other strengths and forms of Ceftazidime
Clinical summary
Ceftazidime is a cephalosporin antibacterial indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in diseases. It is available as powder for injection for intravenous and intramuscular use. MedsAcross supplies Ceftazidime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CeftazidimeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ceftazidime prescribing information (Sagent Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Ceftazidime 6 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.